SynthesisAnnals of medicine2026

Risk of adverse events in elotuzumab-treated patients with multiple myeloma: a systematic review and meta-analysis.

Zhaoyue Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.